1.
4.
New generation adjuvants – From empiricism to rational design
by O’Hagan, Derek T
Vaccine, 2015, Vol.33, p.B14-B20
5.
CpG DNA as a vaccine adjuvant
by Bode, Christian
Expert review of vaccines, 2011, Vol.10 (4), p.499-511
6.
Engineered immunogen binding to alum adjuvant enhances humoral immunity
by Moyer, Tyson J
Nature medicine, 2020, Vol.26 (3), p.430-440
7.
Microbial heat shock protein 70 stimulatory properties have different TLR requirements
by Qazi, Khaleda Rahman
Vaccine, 2006, Vol.25 (6), p.1096-1103
8.
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
by Flavell, Richard A
Nature, 2008, Vol.453 (7198), p.1122-1126
9.
NVX-CoV2373 vaccine protects cynomolgus macaque upper and lower airways against SARS-CoV-2 challenge
by Guebre-Xabier, Mimi
Vaccine, 2020, Vol.38 (50), p.7892-7896
10.
DNA released from dying host cells mediates aluminum adjuvant activity
by Marichal, Thomas
Nature medicine, 2011, Vol.17 (8), p.996-1002
11.
Molecular identification of a danger signal that alerts the immune system to dying cells
by Rock, Kenneth L
Nature, 2003, Vol.425 (6957), p.516-521
12.
Clinical evaluation of CpG oligonucleotides as adjuvants for vaccines targeting infectious diseases and cancer
by Scheiermann, Julia
Vaccine, 2014, Vol.32 (48), p.6377-6389
13.
Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
by Petrovsky, Nikolai
Vaccine, 2015, Vol.33 (44), p.5920-5926
14.
The use of Toll-like receptor 7/8 agonists as vaccine adjuvants
by Vasilakos, John P
Expert review of vaccines, 2013, Vol.12 (7), p.809-819
15.
Nano-microparticles as immune adjuvants: correlating particle sizes and the resultant immune responses
by Oyewumi, Moses O
Expert review of vaccines, 2010, Vol.9 (9), p.1095-1107
16.
Carbohydrate-based immune adjuvants
by Petrovsky, Nikolai
Expert review of vaccines, 2011, Vol.10 (4), p.523-537
17.
The biology of NKT cells
by Bendelac, Albert
Annual Review of Immunology, 2007, Vol.25 (1), p.297-336
18.
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect
by Calabro, Samuele
Vaccine, 2013, Vol.31 (33), p.3363-3369
19.
Polymeric micro/nanoparticles: Particle design and potential vaccine delivery applications
by Yue, Hua
Vaccine, 2015, Vol.33 (44), p.5927-5936
20.
CpG Still Rocks! Update on an Accidental Drug
by Krieg, Arthur M.
Nucleic acid therapeutics, 2012, Vol.22 (2), p.77-89
